STOCK TITAN

Mednow Stock Price, News & Analysis

MDNWF OTC

Welcome to our dedicated page for Mednow news (Ticker: MDNWF), a resource for investors and traders seeking the latest updates and insights on Mednow stock.

Mednow Inc. (MDNWF) is transforming Canadian healthcare access through its digital pharmacy platform, combining medication delivery with virtual care services. This news hub provides investors and industry observers with essential updates about the company's operational milestones and market strategy.

Discover official announcements ranging from quarterly financial results to strategic partnerships and service expansions. Our curated feed simplifies tracking of prescription delivery innovations, telehealth integrations, and regulatory developments in the healthcare technology sector.

Key updates include pharmacy network growth metrics, new provincial service rollouts, and technology platform enhancements. Bookmark this page for streamlined access to Mednow's verified press releases, ensuring you stay informed about initiatives shaping accessible healthcare solutions nationwide.

News
Rhea-AI Summary

Mednow Inc. (OTCQX:MDNWF) has officially opened a new pharmacy facility in Calgary, Alberta, enhancing its national infrastructure and commitment to holistic patient care.

The new location focuses on specialty pharmacy services, particularly in managing complex conditions such as hepatitis C, aiming for disease elimination in Canada by 2030.

This expansion supports Mednow's goal of delivering high-quality, pharmacist-led patient care while driving sustainable business growth.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
9.28%
Tags
none
-
Rhea-AI Summary

Mednow Inc. (TSXV: MNOW) (OTCQX: MDNWF), a Canadian virtual pharmacy, has engaged Gravitas Securities Inc. to offer senior secured convertible debentures, aiming to raise up to $3,000,000. Each Convertible Debenture will be priced at $1,000, bearing interest at 12% annually and maturing in 36 months. Holders can convert them into units at a price of $0.35 per unit, which includes common shares and purchase warrants. Funds will be used for strategic acquisitions and working capital. The offering is subject to TSXV approval.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-18.75%
Tags
none
-
News
Rhea-AI Summary

Mednow Inc. (TSXV: MNOW, OTCQX: MDNWF) reported remarkable Q3 2022 growth, achieving a 225% quarter-over-quarter and 4,800% year-over-year revenue increase. With nine licensed pharmacies across Canada, the company emphasizes digital transformation in healthcare. Significant investments were made in technology and personnel, enhancing their proprietary CRM and patient app. Mednow also acquired Medvisit and established a specialty pharmacy network, positioning itself as a leader in virtual pharmacy services. Despite macroeconomic challenges, management believes the company is significantly undervalued.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-46.34%
Tags
none
Rhea-AI Summary

Mednow has partnered with Aya, a health spending account company, to improve accessibility and affordability of pharmacy services for Aya members in Canada. As the Preferred Pharmacy Partner, Mednow offers discounts on prescription copayments through Aya's prepaid Mastercard®, reducing out-of-pocket expenses. This collaboration aims to enhance patient access to digital pharmacy care and health solutions, reflecting Mednow's commitment to innovative healthcare delivery. Mednow's approach includes free medication delivery, telemedicine services, and a digital interface for prescription management.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-- %
Tags
none
-
Rhea-AI Summary

Mednow Inc. (TSXV:MNOW, OTCQX:MDNWF), a leading Canadian on-demand virtual pharmacy, will participate in the H.C. Wainwright 24th Annual Global Investment Conference from September 12-14, 2022. The company aims to attract new investors and provide updates to existing stakeholders through a presentation available on demand for 30 days. Management will also engage in one-on-one and group meetings with institutional investors, highlighting its commitment to expanding its national presence in Canadian healthcare.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-- %
Tags
conferences
-
Rhea-AI Summary

Mednow Inc. has launched a new pharmacy distribution center in Quebec, expanding its reach with fast, free prescription delivery. The 6,300 sq. ft. facility features virtual and in-person consultations, enhancing holistic patient care. Led by Director of Pharmacy Raji Al-Kurdi, Mednow aims to provide comprehensive services for chronic condition management. This expansion aligns with Mednow's goal to establish a national presence, supporting sustained business growth.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-0.54%
Tags
none
Rhea-AI Summary

Mednow has partnered with HepCURE to eliminate hepatitis C in Canada by 2030. As part of this collaboration, Liver Care Canada will enhance patient access to HepCURE's treatment services, improving medication adherence and treatment outcomes. This partnership aims to expand Liver Care Canada's operations beyond Ontario to the rest of Canada, targeting marginalized populations. The integration of HepCURE's model has already shown success in Vancouver, with 91% of participants diagnosed and 80% linked to care.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-- %
Tags
partnership
-
Rhea-AI Summary

Mednow reported a remarkable Q3/22 revenue increase of 225% quarter-over-quarter, reaching $6.14M, and over 4,800% year-over-year. The patient count also rose by 20% to approximately 23,000. Revenue forecasts for 2022 are set between C$42.5M to C$47.5M, with expectations for 2023 at C$105M to C$110M. The gross margin is projected to improve from 20% in 2022 to 25% in 2023. Moreover, Ali Reyhany will succeed Karim Nassar as CEO starting June 15, 2022.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
35.08%
Tags
management earnings
-
Rhea-AI Summary

Mednow Inc. (TSXV:MNOW, OTCQX:MDNWF), Canada’s on-demand virtual pharmacy, will present at Gravitas Securities Inc.’s 3rd Los Angeles Summit from June 21 to June 24, 2022 at the Beverly Hills Hotel. This event will attract a selective audience of venture capital, family office, and institutional investors from Canada and abroad. Mednow aims to introduce its story to potential investors and provide updates to existing ones. The company emphasizes its commitment to accessibility and quality healthcare through virtual pharmacy and telemedicine services.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-2.25%
Tags
conferences
Rhea-AI Summary

Mednow Inc. (OTCQX:MDNWF), Canada's on-demand virtual pharmacy, has commenced trading on the OTCQX Best Market, enhancing its visibility to U.S. investors. This milestone simplifies the investment process by eliminating the need for a Canadian trading account. Mednow's shares will continue to trade on the TSX Venture Exchange under the symbol MNOW. The OTCQX Best Market is designed for established companies meeting high financial standards and robust corporate governance.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-- %
Tags
none

FAQ

What is the market cap of Mednow (MDNWF)?

The market cap of Mednow (MDNWF) is approximately 517.3K.
Mednow

OTC:MDNWF

MDNWF Rankings

MDNWF Stock Data

517.29k
15.58M
39.75%
Health Information Services
Healthcare
Link
Canada
Vancouver